drug · protein
insulin aspart
pre_registrationupdated 3mo agoby Gan & Lee Pharmaceuticals Co Ltd🔗 ChEMBL
community read0 votes
🐶 often sniffed alongside
top 7- druginsulin4 co-mentions · 1 sources
- tagType 2 Diabetes4 co-mentions · 1 sources
- drugFiasp4 co-mentions · 1 sources
- drugType 2 Diabetes2 co-mentions · 1 sources
- companyGan & Lee Pharmaceuticals Co Ltd2 co-mentions · 1 sources
- tagEndocrinology & Metabolism2 co-mentions · 1 sources
- drug(insulin aspart + insulin aspart protamine)2 co-mentions · 1 sources
Protein drug with a maximum clinical stage of Approval (across all indications), with an approval for diabetes mellitus and 7 investigational indications.
targets
Insulin receptor
all catalysts(0)
nothing on the calendar yet
Trials studying insulin aspart
- phase3A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
- phase2Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes
- —An Indian Post Marketing Study of Mealtime Insulin, Fiasp®, to Evaluate Its Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice
- phase1A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 2 Diabetes When Given by an Insulin Pump
- —A Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects the Blood Sugar Level in Patients With Type 1 Diabetes as Part of Local Clinical Practice
- phase3A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)
- phase3A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)
- phase3Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With Diabetes
News(1)
- Breast Cancer Experts Preview Abstracts to Watch at the 2026 ESMO Breast Cancer CongressExperts in a range of breast cancer subtypes highlight research data being presented at the 2026 ESMO Breast Cancer Congress.onclive · 3mo ago
Data sources
last refreshed 30m ago
Found something off?
comments(0)
5-min edit window · permanent after that